腰臀比与心脏代谢特征、2型糖尿病及冠心病的遗传关联
研究构建了校正体重指数的腰臀比多基因风险评分(48个单核苷酸多态性),采用孟德尔随机化分析合并多项全基因组关联研究及英国生物银行个体数据,发现该评分升高与甘油三酯、2小时血糖、收缩压升高及2型糖尿病和冠心病风险增加相关,支持腹部肥胖与这些结局存在因果关联。
要点
- 校正体重指数的腰臀比遗传评分每升高1个标准差,2型糖尿病风险OR为1.77,冠心病风险OR为1.46。
- 该评分每升高1个标准差与甘油三酯升高27 mg/dL、2小时血糖升高4.1 mg/dL、收缩压升高2.1 mm Hg相关(各P < .001)。
- 结果支持腹部肥胖与2型糖尿病及冠心病之间存在因果关联。
核心结论
- 校正体重指数的腰臀比遗传倾向升高与2型糖尿病和冠心病风险增加相关,结果支持腹部肥胖与这些结局存在因果关联。
研究设计与样本
- 采用孟德尔随机化分析,合并病例对照与横断面数据集。
- 腰臀比多基因风险评分基于48个单核苷酸多态性构建,并校正体重指数。
- 心脏代谢特征估计基于4项全基因组关联研究(2007至2015年)的汇总结果(最多322 154名参与者)及英国生物银行2007至2011年收集的111 986名个体横断面数据。
- 2型糖尿病和冠心病估计分别基于2项全基因组关联研究(2007至2015年)的汇总统计(分别包含149 821名和184 305名个体),并结合英国生物银行个体数据。
主要发现
- 英国生物银行111 986名个体平均年龄57(SD,8)岁,58 845名(52.5%)为女性,平均腰臀比为0.875。
- 校正体重指数的腰臀比经多基因风险评分介导每升高1个标准差,与甘油三酯升高27 mg/dL、2小时血糖升高4.1 mg/dL、收缩压升高2.1 mm Hg相关(各P < .001)。
- 校正体重指数的腰臀比遗传评分每升高1个标准差,与2型糖尿病风险升高相关(OR,1.77 [95%CI,1.57-2.00];每1000参与者年绝对风险增加6.0 [95%CI,4.4-7.8];2型糖尿病结局人数40 530)。
- 校正体重指数的腰臀比遗传评分每升高1个标准差,与冠心病风险升高相关(OR,1.46 [95%CI,1.32-1.62];每1000参与者年绝对风险增加1.8 [95%CI,1.3-2.4];冠心病结局人数66 440)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In observational studies, abdominal adiposity has been associated with type 2 diabetes and coronary heart disease (CHD). Whether these associations represent causal relationships remains uncertain. OBJECTIVE: To test the association of a polygenic risk score for waist-to-hip ratio (WHR) adjusted for body mass index (BMI), a measure of abdominal adiposity, with type 2 diabetes and CHD through the potential intermediates of blood lipids, blood pressure, and glycemic phenotypes. DESIGN, SETTING, AND PARTICIPANTS: A polygenic risk score for WHR adjusted for BMI, a measure of genetic predisposition to abdominal adiposity, was constructed with 48 single-nucleotide polymorphisms. The association of this score with cardiometabolic traits, type 2 diabetes, and CHD was tested in a mendelian randomization analysis that combined case-control and cross-sectional data sets. Estimates for cardiometabolic traits were based on a combined data set consisting of summary results from 4 genome-wide association studies conducted from 2007 to 2015, including up to 322 154 participants, as well as individual-level, cross-sectional data from the UK Biobank collected from 2007-2011, including 111 986 individuals. Estimates for type 2 diabetes and CHD were derived from summary statistics of 2 separate genome-wide association studies conducted from 2007 to 2015 and including 149 821 individuals and 184 305 individuals, respectively, combined with individual-level data from the UK Biobank. EXPOSURES: Genetic predisposition to increased WHR adjusted for BMI. MAIN OUTCOMES AND MEASURES: Type 2 diabetes and CHD. RESULTS: Among 111 986 individuals in the UK Biobank, the mean age was 57 (SD, 8) years, 58 845 participants (52.5%) were women, and mean WHR was 0.875. Analysis of summary-level genome-wide association study results and individual-level UK Biobank data demonstrated that a 1-SD increase in WHR adjusted for BMI mediated by the polygenic risk score was associated with 27-mg/dL higher triglyceride levels, 4.1-mg/dL higher 2-hour glucose levels, and 2.1-mm Hg higher systolic blood pressure (each P < .001). A 1-SD genetic increase in WHR adjusted for BMI was also associated with a higher risk of type 2 diabetes (odds ratio, 1.77 [95% CI, 1.57-2.00]; absolute risk increase per 1000 participant-years, 6.0 [95% CI, CI, 4.4-7.8]; number of participants with type 2 diabetes outcome, 40 530) and CHD (odds ratio, 1.46 [95% CI, 1.32-1.62]; absolute risk increase per 1000 participant-years, 1.8 [95% CI, 1.3-2.4]; number of participants with CHD outcome, 66 440). CONCLUSIONS AND RELEVANCE: A genetic predisposition to higher waist-to-hip ratio adjusted for body mass index was associated with increased risk of type 2 diabetes and coronary heart disease. These results provide evidence supportive of a causal association between abdominal adiposity and these outcomes.
引用
- Emdin CA, Khera AV, Natarajan P, et al. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease. JAMA. 2017. PMID: 28196256. doi:10.1001/jama.2016.21042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。